Comparative study on the effects of cyclosporin A in renal cells in culture

被引:7
作者
Nascimento, CR
Braga, F
Capella, LS
Santos, OR
Lopes, AG
Capellaa, MAM
机构
[1] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, BR-21949900 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Dept Clin Med, BR-21949900 Rio De Janeiro, Brazil
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2005年 / 99卷 / 03期
关键词
cyclosporin A; Rhodamine; 123; MitoTracker green; ABCB1; flow cytometry; LLC-PK1; Ma104; MDCK;
D O I
10.1159/000083415
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Although cyclosporin A (CSA) inhibits P-glycoprotein (ABCB1), the relationship between this inhibition and CSA-induced nephrotoxicity is not established. Methods: Three renal cell lines were used to investigate the effects of CSA in cellular viability and accumulation of rhodamine 123 ( Rho123): LLC-PK1, which does not express ABCB1 substantially; MDCK, expressing moderate amounts of this protein, and Ma104 cells, which express high amounts of ABCB1. Results: The viability was significantly reduced in the three cell lines after treatment with CSA concentrations >10 muM. Ma104 was the more resistant and LLC-PK1 the more sensitive. CSA increased Rho123 accumulation in the three cell lines when incubated simultaneously, MDCK presenting the higher increase. However, different results were achieved when the periods of incubation with Rho123 and CSA were disconnected: a post-incubation with CSA was more effective in Ma104 cells, while MDCK and LLC-PK1 showed no difference between pre-, co- and post-incubation with CSA. Conclusions: Our results suggest that the effects of CSA may be divided into two groups: ABCB1-independent ( direct injury), and ABCB1-dependent toxicity, due to modulation of its activity. This could result in increased accumulation of noxious ABCB1 substrates, contributing to CSA-induced nephrotoxicity. Furthermore, the mechanisms of ABCB1 modulation by CSA may be different for different cell lines. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 44 条
  • [1] Regulation of renal tubular secretion of organic compounds
    Berkhin, EB
    Humphreys, MH
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (01) : 17 - 30
  • [2] BIOLOGICAL EFFECTS OF CYCLOSPORIN-A - NEW ANTILYMPHOCYTIC AGENT
    BOREL, JF
    FEURER, C
    GUBLER, HU
    STAHELIN, H
    [J]. AGENTS AND ACTIONS, 1976, 6 (04): : 468 - 475
  • [3] Cyclosporine A amplifies Ca2+ signaling pathway in LLC-PK1 cells through the inhibition of plasma membrane Ca2+ pump
    Calderaro, V
    Boccellino, M
    Cirillo, G
    Quagliuolo, L
    Cirillo, D
    Giovane, A
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1435 - 1442
  • [4] Reduced glutathione protect cells from ouabain toxicity
    Capella, LS
    Gefé, M
    Silva, EF
    Morales, MM
    Affonso-Mitidieri, O
    Lopes, AG
    Rumjanek, VM
    Capella, MAM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2001, 1526 (03): : 293 - 300
  • [5] Capella MAM, 1999, Z NATURFORSCH C, V54, P119
  • [6] DELMORAL RG, 1995, AM J PATHOL, V146, P398
  • [7] Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites
    Demeule, M
    Laplante, A
    Sepehr-Araé, A
    Beaulieu, É
    Averill-Bates, D
    Wenger, RM
    Béliveau, R
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 1999, 77 (01) : 47 - 58
  • [8] NEPHROTOXICITY OF CYCLOSPORINE-A IN HUMANS - EFFECTS ON GLOMERULAR-FILTRATION AND TUBULAR REABSORPTION RATES
    DIEPERINK, H
    LEYSSAC, PP
    KEMP, E
    STARKLINT, H
    FRANDSEN, NE
    TVEDES, N
    MOLLER, J
    FREDERIKSEN, PB
    ROSSING, N
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1987, 17 (06) : 493 - 496
  • [9] Discrimination of depolarized from polarized mitochondria by confocal fluorescence resonance energy transfer
    Elmore, SP
    Nishimura, Y
    Qian, T
    Herman, B
    Lemasters, JJ
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 422 (02) : 145 - 152
  • [10] CYCLOSPORINE THERAPY FOR AUTOIMMUNE-DISEASE
    FATHMAN, CG
    MYERS, BD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (25) : 1693 - 1695